Status:
COMPLETED
The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
Lead Sponsor:
Momentum Data
Collaborating Sponsors:
Pfizer
University of Surrey
Conditions:
Venous Thromboses
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Brief Summary
Blood clots occurring in the legs and in the lungs are relatively common; they occur in around 3 in a 1000 people per year. They can cause disability and are also potentially life threatening. When a ...
Detailed Description
Background Venous thromboembolism (VTE), comprising pulmonary embolism (PE) and deep vein thrombosis (DVT), are common and associated with significant morbidity and mortality. VTE risk is higher in c...
Eligibility Criteria
Inclusion
- Adult patients (aged ≥18) contributing to RCGP RCS primary care database between January 1, 1998 and January 1, 2018, will be eligible for inclusion
Exclusion
- People with IBD which cannot be classified or is not ulcerative colitis or Crohn's disease will be excluded.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
266890 Patients enrolled
Trial Details
Trial ID
NCT03835780
Start Date
February 1 2019
End Date
December 1 2019
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Momentum Data Ltd
London, United Kingdom, WC1X 8QT